News

MD Anderson’s Moon Shots Program would help in reducing cancer deaths by targeting eight cancers with the support of several new research platforms that provide infrastructure, expertise and

ATAGI has recommended Bexsero (meningococcal group B vaccine [rDNA, component, adsorbed]) for all young Australians, with an emphasis on infants and children under two years of age and

As part of the deal, Tesaro will receive rights to monospecific antibody drug candidates targeting TIM-3, LAG-3 and PD-1 and dual reactive antibody drug candidates targeting PD-1/TIM-3 and

SmartFactory is a single-use cGMP bio-manufacturing capacity, which will help Alvotech to rapidly expand its biosimilars business. Finesse’s customers will also have access to Alvogen’s commercial, FDA approved,

The company plans to submit a protocol to the US Food and Drug Administration (FDA) in the first half of 2014 for a Phase I/II clinical trial to

Ferrer is Alexza’s commercial partner for Adasuve in the EU, Latin America and the Commonwealth of Independent States countries. Ferrer is commercializing the product in Romania through a

Saama Sales Operations Solution for Life Science is an integrated data and analytics platform that supports the drug commercialization process by automating sales operations and analytics. As part

BHV is a privately held pharmaceutical company developing the SGLT2 inhibitor remogliflozin etabonate (remogliflozin) for type 2 diabetes and non-alcoholic steatohepatitis (NASH). Remogliflozin is currently in Phase II

This facility has been reconfigured to provide for 30 semi-private rooms to give each clinical trial volunteer a more comfortable experience for extended in-house stays. This dedicated clinical